TransCode Therapeutics Up 9.4% After CEO and CFO Report Stock Purchases
By Josh Beckerman Shares of TransCode Therapeutics rose 9.4% Tuesday after the company's chief executive and chief financial officer reported stock...
Source: marketwatch.com
Page 6 - Transcode Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Transcode Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Transcode Therapeutics Today - Breaking & Trending Today
TransCode Therapeutics, Inc. (NASDAQ:RNAZ) Short Interest Up 418.0% in September
TransCode Therapeutics, Inc. (NASDAQ:RNAZ – Get Free Report) saw a significant increase in short interest in the month of September. As of September 15th, there was short interest totalling 126,400 shares, an increase of 418.0% from the August 31st total of 24,400 shares. Approximately 7.1% of the company’s shares are sold short. Based on an […]
Source: modernreaders.com
Transcode Therapeutics stock whipsaws lower after cut price placing
TransCode Therapeutics (NASDAQ:RNAZ) stock has seen a wild 24 hours of trading as the Boston headquartered nano-cap drug discovery firm rocketed Monday,...
Source: proactiveinvestors.com
TransCode Therapeutics stock skyrockets on positive brain cancer trial results
TransCode Therapeutics (NASDAQ:RNAZ) shares took off after it announced positive results from a study of its lead drug candidate TTX-MC138 in mice models...
Source: proactiveinvestors.com
TransCode Therapeutics Announces Pricing of $8 Million
BOSTON, Sept. 25, 2023 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ), (the “Company”), an RNA oncology company committed to more...
Source: globenewswire.com